Lecap Asset Management Ltd. Acquires Shares of 4,896 Azenta, Inc. (NASDAQ:AZTA)

Lecap Asset Management Ltd. bought a new stake in Azenta, Inc. (NASDAQ:AZTA) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,896 shares of the company’s stock, valued at approximately $319,000.

Several other institutional investors and hedge funds also recently made changes to their positions in AZTA. FMR LLC purchased a new position in shares of Azenta in the second quarter worth about $172,000. Credit Suisse AG purchased a new position in shares of Azenta in the second quarter worth about $4,451,000. LPL Financial LLC purchased a new position in shares of Azenta in the second quarter worth about $3,697,000. Millennium Management LLC purchased a new position in shares of Azenta in the second quarter worth about $6,091,000. Finally, Cubist Systematic Strategies LLC purchased a new position in shares of Azenta in the second quarter worth about $736,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Azenta Stock Performance

AZTA stock opened at $53.55 on Tuesday. The company has a market capitalization of $2.99 billion, a PE ratio of -172.74 and a beta of 1.53. Azenta, Inc. has a one year low of $36.01 and a one year high of $69.16. The company’s 50 day moving average price is $61.81 and its two-hundred day moving average price is $59.01.

Azenta (NASDAQ:AZTA) last issued its earnings results on Wednesday, February 7th. The company reported $0.02 EPS for the quarter. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. The company had revenue of $154.32 million for the quarter, compared to the consensus estimate of $151.86 million. On average, research analysts predict that Azenta, Inc. will post 0.27 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Jefferies Financial Group assumed coverage on shares of Azenta in a research report on Thursday, April 4th. They issued a “hold” rating and a $64.00 price objective for the company. Evercore ISI cut their price objective on shares of Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a research report on Thursday, April 4th. Stephens restated an “equal weight” rating and issued a $70.00 price objective on shares of Azenta in a research report on Thursday, February 8th. Needham & Company LLC restated a “buy” rating and issued a $75.00 price objective on shares of Azenta in a research report on Monday, April 8th. Finally, B. Riley raised their price objective on shares of Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $69.60.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.